<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - CIPROFLOXACIN</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drug/">Drugs</a></li>
      </ul>

      <h1>CIPROFLOXACIN</h1>

        <p><a href="../drugClass/PHP34649.html">QUINOLONES</a></p>

      <nav>
        <ul class="nav nav-list">

          <li class="active"><a href="#indicationsAndDoses" data-toggle="tab">Indications and doses</a></li>
          <li><a href="#pregnancy" data-toggle="tab">Pregnancy</a></li>
          <li><a href="#renalImpairment" data-toggle="tab">Renal impairment</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#patientAndCarerAdvice" data-toggle="tab">Patient and carer advice</a></li>
          <li><a href="#cautions" data-toggle="tab">Cautions</a></li>
          <li><a href="#unlicensedUse" data-toggle="tab">Unlicensed use</a></li>
          <li><a href="#prescribingAndDispensingInformation" data-toggle="tab">Prescribing and dispensing</a></li>
          <li><a href="#medicinalForms" data-toggle="tab">Medicinal forms</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">

      <section class="tab-pane active" id="indicationsAndDoses">
        <h2>Indications and doses</h2>

        <section class="indicationAndDoseGroups">
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Superficial bacterial eye infection</span>,
            </h4>
            <p class="specificity"><span class="route">To the eye using eye ointment</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Apply 4 times a day for maximum duration of treatment 21 days.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                Apply 1.25 centimetres 3 times a day for 2 days, then apply 1.25 centimetres twice daily for 5 days.</li>
              <li class="dose child"><strong>For children </strong><br/>
                Apply 4 times a day for maximum duration of treatment 21 days.</li>
              <li class="dose child"><strong>For children 1&#8211;17 years</strong><br/>
                Apply 1.25 centimetres 3 times a day for 2 days, then apply 1.25 centimetres twice daily for 5 days.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Superficial bacterial eye infection (severe infection)</span>,
            </h4>
            <p class="specificity"><span class="route">To the eye using eye drop</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Apply every 2 hours during waking hours for 2 days, then apply 4 times a day for maximum duration of treatment 21 days.</li>
              <li class="dose child"><strong>For children </strong><br/>
                Apply every 2 hours during waking hours for 2 days, then apply 4 times a day for maximum duration of treatment 21 days.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Corneal ulcer</span>,
            </h4>
            <p class="specificity"><span class="route">To the eye using eye ointment</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Apply every 15 minutes for 6 hours, then apply every 30 minutes for the remainder of day 1, then apply every 1 hour on day 2, then apply every 4 hours on days 3&#8211;14, maximum duration of treatment 21 days, to be administered throughout the day and night.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                Apply 1.25 centimetres every 1&#8211;2 hours for 2 days, then apply 1.25 centimetres every 4 hours for the next 12 days, to be administered throughout the day and night.</li>
              <li class="dose child"><strong>For children </strong><br/>
                Apply every 15 minutes for 6 hours, then apply every 30 minutes for the remainder of day 1, then apply every 1 hour on day 2, then apply every 4 hours on days 3&#8211;14, maximum duration of treatment 21 days, to be administered throughout the day and night.</li>
              <li class="dose child"><strong>For children 1&#8211;17 years</strong><br/>
                Apply 1.25 centimetres every 1&#8211;2 hours for 2 days, then apply 1.25 centimetres every 4 hours for the next 12 days, to be administered throughout the day and night.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Fistulating Crohn's disease</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                500 mg twice daily.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Respiratory-tract infections</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous infusion</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                500&#8211;750 mg twice daily.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                400 mg every 8&#8211;12 hours, to be given over 60 minutes.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Pseudomonal lower respiratory-tract infection in cystic fibrosis</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                750 mg twice daily.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Urinary-tract infections</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous infusion</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                250&#8211;750 mg twice daily.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                400 mg every 8&#8211;12 hours, to be given over 60 minutes.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Acute uncomplicated cystitis in women</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                250 mg twice daily for 3 days.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Acute or chronic prostatitis</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous infusion</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                500 mg twice daily for 28 days.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                400 mg every 8&#8211;12 hours, to be given over 60 minutes.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Gonorrhoea</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                500 mg for 1 dose.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Most other infections</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous infusion</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Initially 500 mg twice daily; increased to 750 mg twice daily, in severe or deep-seated infection.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                400 mg every 8&#8211;12 hours, to be given over 60 minutes.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Surgical prophylaxis</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                750 mg, to be taken 60 minutes before procedure.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Anthrax (treatment and post-exposure prophylaxis)</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous infusion</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                500 mg twice daily.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                400 mg every 12 hours, to be given over 60 minutes.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Prevention of secondary case of meningococcal meningitis</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                500 mg for 1 dose.</li>
              <li class="dose child"><strong>For children 1 month&#8211;4 years</strong><br/>
                30 mg/kg (max. per dose 125 mg) for 1 dose.</li>
              <li class="dose child"><strong>For children 5&#8211;11 years</strong><br/>
                250 mg for 1 dose.</li>
              <li class="dose child"><strong>For children 12&#8211;17 years</strong><br/>
                500 mg for 1 dose.</li>
            </ul>
          </section>
        </section>
        
        
        
        
        
      </section>



      <section class="tab-pane" id="pregnancy">
        <h2>Advice when patient is pregnant</h2>

            <section class="generalInformation">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use or <ph outputclass="route">oral</ph> use</h3>
              <p>A single dose of ciprofloxacin may be used for the prevention of a secondary case of meningococcal meningitis.</p>
            </section>
            <section class="generalInformation">
              <h3 class="specificity">When used by <ph outputclass="route">eye</ph></h3>
              <p>Manufacturer advises use only if potential benefit outweighs risk.</p>
            </section>
      </section>


      <section class="tab-pane" id="renalImpairment">
        <h2>Advice regarding renal impairment</h2>

            <section class="doseAdjustments">
              <h3 class="specificity">With <ph outputclass="route">oral</ph> use in adults</h3>
              <p>Give 250&#8211;500&#8239;mg every 12 hours if eGFR 30&#8211;60&#8239;mL/minute/1.73&#8239;m<sup>2</sup> (every 24 hours if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>).</p>
            </section>
            <section class="doseAdjustments">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use in adults</h3>
              <p>Give (200&#8239;mg over 30 minutes), 200&#8211;400&#8239;mg every 12 hours if eGFR 30&#8211;60&#8239;mL/minute/ 1.73m<sup>2</sup> (every 24 hours if eGFR less than 30&#8239;mL/ minute/1.73&#8239;m<sup>2</sup>).</p>
            </section>
            <section class="doseAdjustments">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use or <ph outputclass="route">oral</ph> use in children</h3>
              <p>Reduce dose if estimated glomerular filtration rate less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>&#8212;consult product literature.</p>
            </section>
        
      </section>


      <section class="tab-pane" id="sideEffects">
        <h2>Known side effects</h2>

        
          <h3>Specific side effects</h3>
              <p>
                <strong>commonOrVeryCommon:</strong> corneal deposits (reversible after completion of treatment), ocular discomfort, ocular hyperaemia, taste disturbance, flatulence, pain at injection site, phlebitis at injection site, flatulence,
              </p>
              <p>
                <strong>uncommon:</strong> increased lacrimation, blurred vision, conjunctival hyperaemia, corneal infiltrates, corneal staining, eye dryness, eye irritation, eye pain, eye pruritus, eye swelling, eyelid disorders, eyelid erythema, eyelid exfoliation, eyelid oedema, headache, keratopathy, nausea, photophobia,
              </p>
              <p>
                <strong>rare:</strong> abdominal pain, asthenopia, corneal disorders, corneal epithelium defect, dermatitis, diarrhoea, diplopia, dizziness, ear pain, eye hypoaesthesia, keratitis, paranasal sinus hypersecretion, rhinitis, abnormal dreams, chest pain, dysphagia, dyspnoea, erythema nodosum, hot flushes, hyperglycaemia, hypoglycaemia, oedema, pancreatitis, sweating, syncope, tachycardia, abnormal dreams, chest pain, dysphagia, dyspnoea, erythema nodosum, hot flushes, hyperglycaemia, hypoglycaemia, oedema, pancreatitis, sweating, syncope, tachycardia,
              </p>
              <p>
                <strong>veryRare:</strong> intracranial hypertension, movement disorders, tenosynovitis, tinnitus, vasculitis in children, intracranial hypertension, movement disorders, tenosynovitis, tinnitus, vasculitis in children,
              </p>
              <p>
                <strong>notKnown:</strong> peripheral neuropathy, polyneuropathy, peripheral neuropathy, polyneuropathy,
              </p>
        
        
      </section>


      <section class="tab-pane" id="patientAndCarerAdvice">
        <h2>Advice for patients and carers</h2>

            <section class="patientResources">
              <h3 class="specificity">In children</h3>
                <p class="title">Medicines for Children leaflet: Ciprofloxacin ear drops for ear infections</p>
              <p>
            <xref format="html" href="http://www.medicinesforchildren.org.uk/ciprofloxacin-ear-drops-ear-infections-0">www.medicinesforchildren.org.uk/ciprofloxacin-ear-drops-ear-infections-0</xref>
            </p>
            </section>
            <section class="patientResources">
              <h3 class="specificity">In children</h3>
                <p class="title">Medicines for Children leaflet: Ciprofloxacin for bacterial infections</p>
              <p>
            <xref format="html" href="http://www.medicinesforchildren.org.uk/ciprofloxacin-bacterial-infections-0">www.medicinesforchildren.org.uk/ciprofloxacin-bacterial-infections-0</xref>
            </p>
            </section>
      </section>



      <section class="tab-pane" id="cautions">
        <h2>Cautions regarding administration</h2>

        <ul>
          <li>
              <strong>With intravenous use:</strong>
            acute myocardial infarction (risk factor for QT interval prolongation)
          </li>
          <li>
              <strong>With intravenous use:</strong>
            avoid excessive alkalinity of urine (risk of crystalluria)
          </li>
          <li>
              <strong>With intravenous use:</strong>
            bradycardia (risk factor for QT interval prolongation)
          </li>
          <li>
              <strong>With intravenous use:</strong>
            congenital long QT syndrome (risk factor for QT interval prolongation)
          </li>
          <li>
              <strong>With intravenous use:</strong>
            electrolyte disturbances (risk factor for QT interval prolongation)
          </li>
          <li>
              <strong>With intravenous use:</strong>
            ensure adequate fluid intake (risk of crystalluria)
          </li>
          <li>
              <strong>With intravenous use:</strong>
            heart failure with reduced left ventricular ejection fraction (risk factor for QT interval prolongation)
          </li>
          <li>
              <strong>With intravenous use:</strong>
            history of symptomatic arrhythmias (risk factor for QT interval prolongation)
          </li>
          <li>
              <strong>With oral use:</strong>
            acute myocardial infarction (risk factor for QT interval prolongation)
          </li>
          <li>
              <strong>With oral use:</strong>
            avoid excessive alkalinity of urine (risk of crystalluria)
          </li>
          <li>
              <strong>With oral use:</strong>
            bradycardia (risk factor for QT interval prolongation)
          </li>
          <li>
              <strong>With oral use:</strong>
            congenital long QT syndrome (risk factor for QT interval prolongation)
          </li>
          <li>
              <strong>With oral use:</strong>
            electrolyte disturbances (risk factor for QT interval prolongation)
          </li>
          <li>
              <strong>With oral use:</strong>
            ensure adequate fluid intake (risk of crystalluria)
          </li>
          <li>
              <strong>With oral use:</strong>
            heart failure with reduced left ventricular ejection fraction (risk factor for QT interval prolongation)
          </li>
          <li>
              <strong>With oral use:</strong>
            history of symptomatic arrhythmias (risk factor for QT interval prolongation)
          </li>
        </ul>
      </section>



      <section class="tab-pane" id="unlicensedUse">
        <h2>Unlicensed use</h2>

            <section class="unlicensedUse">
              <h3 class="specificity">When used by <ph outputclass="route">eye</ph> in children</h3>
              <p>Eye ointment not licensed for use in children under 1 year.</p>
            </section>
            <section class="unlicensedUse">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use or <ph outputclass="route">oral</ph> use in children</h3>
              <p>Not licensed for use in children under 1 year of age.</p><p>Licensed for use in children over 1 year for complicated urinary-tract infections, for pseudomonal lower respiratory-tract infections in cystic fibrosis, for prophylaxis and treatment of inhalational anthrax. Licensed for use in children over 1 year for other infections where the benefit is considered to outweigh the potential risks.</p><p>Not licensed for use in children for gastro-intestinal anthrax.</p><p>Not licensed for use in children for prophylaxis of meningococcal meningitis.</p>
            </section>
      </section>

      <section class="tab-pane" id="prescribingAndDispensingInformation">
        <h2>Information regarding prescribing and dispensing</h2>

            <section class="prescribingAndDispensingInformation">
              <p>Flavours of oral liquid formulations may include strawberry.</p>
            </section>
      </section>









      <section class="tab-pane" id="medicinalForms">
        <h2>Prepared medicinal forms of CIPROFLOXACIN</h2>


            <section class="licensingVariationStatement">
              <p>There can be variation in the licensing of different medicines containing the same drug.</p>
            </section>
        
          <strong>Forms available from special-order manufacturers include: </strong>
            eye drops,
            oral suspension,
            ear drops,

            <div id="PHP74800"><a href="../medicinalForm/PHP74800.html" data-target="#PHP74800" data-action="load">Tablet</a></div>
            <div id="PHP74827"><a href="../medicinalForm/PHP74827.html" data-target="#PHP74827" data-action="load">Oral suspension</a></div>
            <div id="PHP74807"><a href="../medicinalForm/PHP74807.html" data-target="#PHP74807" data-action="load">Infusion</a></div>
            <div id="PHP74820"><a href="../medicinalForm/PHP74820.html" data-target="#PHP74820" data-action="load">Solution for infusion</a></div>
            <div id="PHP74848"><a href="../medicinalForm/PHP74848.html" data-target="#PHP74848" data-action="load">Eye drops</a></div>
            <div id="PHP74813"><a href="../medicinalForm/PHP74813.html" data-target="#PHP74813" data-action="load">Eye ointment</a></div>
      </section>
    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
  <script src="/content/scripts/NICE.RemoteLoad.js"></script>
</html>
